These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9701237)

  • 21. Effect of folic acid fortification on prevalence of neural tube defects in Rhode Island.
    Lambert-Messerlian G; Halliday J; Williams J; Cain R; Msall ME; Palomaki GE; Canick JA
    J Med Screen; 2004; 11(2):106-7. PubMed ID: 15153328
    [No Abstract]   [Full Text] [Related]  

  • 22. Association of the 677C-->T mutation on the methylenetetrahydrofolate reductase gene in Turkish patients with neural tube defects.
    Boduroğlu K; Alikaşifoğlu M; Anar B; Tunçbilek E
    J Child Neurol; 1999 Mar; 14(3):159-61. PubMed ID: 10190266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Methylenetetrahydrofolate reductase mutation and neural tube defects.
    Kirke PN; Mills JL; Whitehead AS; Molloy A; Scott JM
    Lancet; 1996 Oct; 348(9033):1037-8. PubMed ID: 8855891
    [No Abstract]   [Full Text] [Related]  

  • 24. Role of amniotic fluid homocysteine level and of fetal 5, 10-methylenetetrahydrafolate reductase genotype in the etiology of neural tube defects.
    Wenstrom KD; Johanning GL; Owen J; Johnston KE; Acton S; Tamura T
    Am J Med Genet; 2000 Jan; 90(1):12-6. PubMed ID: 10602111
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of neural tube defects and folic acid food fortification in Canada.
    Ray JG; Meier C; Vermeulen MJ; Boss S; Wyatt PR; Cole DE
    Lancet; 2002 Dec 21-28; 360(9350):2047-8. PubMed ID: 12504403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Folic acid for the prevention of congenital anomalies.
    Hall J; Solehdin F
    Eur J Pediatr; 1998 Jun; 157(6):445-50. PubMed ID: 9667396
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differentiating between fetal and maternal genotypic effects, using the transmission test for linkage disequilibrium.
    Mitchell LE
    Am J Hum Genet; 1997 Apr; 60(4):1006-7. PubMed ID: 9106551
    [No Abstract]   [Full Text] [Related]  

  • 28. Comparing the observed and predicted effectiveness of folic acid fortification in preventing neural tube defects.
    Palomaki GE; Williams J; Haddow JE
    J Med Screen; 2003; 10(1):52-3. PubMed ID: 12790316
    [No Abstract]   [Full Text] [Related]  

  • 29. C677T mutation in methylenetetrahydrofolate reductase gene and neural tube defects: should Japanese women undergo gene screening before pregnancy?
    Kondo A; Fukuda H; Matsuo T; Shinozaki K; Okai I
    Congenit Anom (Kyoto); 2014 Feb; 54(1):30-4. PubMed ID: 24588777
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Homocysteine and cardiovascular disease.
    Scott J; Weir D
    QJM; 1996 Aug; 89(8):561-3. PubMed ID: 8935476
    [No Abstract]   [Full Text] [Related]  

  • 31. [Molecular genetics of the remethylation of homocysteine].
    Chango A; Parrot-Roulaud F; Nicolas J
    Ann Biol Clin (Paris); 1999; 57(1):37-42. PubMed ID: 9920965
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Spina bifida, anencephaly, and folic acid: what do they have to do with neurosurgery?
    Ausman JI; Slavin KV
    Surg Neurol; 1995 Feb; 43(2):120-1. PubMed ID: 7892654
    [No Abstract]   [Full Text] [Related]  

  • 33. Low blood folates in NTD pregnancies are only partly explained by thermolabile 5,10-methylenetetrahydrofolate reductase: low folate status alone may be the critical factor.
    Molloy AM; Mills JL; Kirke PN; Ramsbottom D; McPartlin JM; Burke H; Conley M; Whitehead AS; Weir DG; Scott JM
    Am J Med Genet; 1998 Jun; 78(2):155-9. PubMed ID: 9674907
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Supplementation with folic acid before and during pregnancy].
    Saussele T
    Med Monatsschr Pharm; 2008 Dec; 31(12):469-72. PubMed ID: 19133595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The unnecessary epidemic of folic acid-preventable spina bifida and anencephaly.
    Brent RL; Oakley GP; Mattison DR
    Pediatrics; 2000 Oct; 106(4):825-7. PubMed ID: 11015526
    [No Abstract]   [Full Text] [Related]  

  • 36. Neural tube defects: Risk factors and preventive measures.
    Kondo A; Matsuo T; Morota N; Kondo AS; Okai I; Fukuda H
    Congenit Anom (Kyoto); 2017 Sep; 57(5):150-156. PubMed ID: 28425110
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Genetic risk factors of neural tube defects].
    Sliwerska E; Szpecht-Potocka A
    Med Wieku Rozwoj; 2002; 6(4):349-70. PubMed ID: 12810987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neural tube defects.
    Freeman NV; Rajab A
    Trop Doct; 1999 Oct; 29(4):235-7. PubMed ID: 10578641
    [No Abstract]   [Full Text] [Related]  

  • 39. Amniotic fluid homocysteine levels, 5,10-methylenetetrahydrafolate reductase genotypes, and neural tube closure sites.
    Wenstrom KD; Johanning GL; Owen J; Johnston KE; Acton S; Cliver S; Tamura T
    Am J Med Genet; 2000 Jan; 90(1):6-11. PubMed ID: 10602110
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Methylene tetrahydrofolate reductase mutations as genetic risk factors for neural tube defects (NTF)].
    Mierzejewska E
    Med Wieku Rozwoj; 1999; 3(4):521-7. PubMed ID: 10910677
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.